ClinicalTrials.Veeva

Menu

iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes

J

Julia Blanchette

Status

Enrolling

Conditions

Type 1 Diabetes

Treatments

Behavioral: iHERO Toolkit Resource

Study type

Interventional

Funder types

Other

Identifiers

NCT06348160
STUDY20230187

Details and patient eligibility

About

This research study aims to test a financial and health insurance iHERO Toolkit for young adults with type1 diabetes. The iHERO Toolkit was developed over one year with the type 1 diabetes community, The Diabetes Link organization, and experts. Now, the investigators want to understand the impact of the iHERO Toolkit on diabetes self-management, financial stress, and health insurance literacy outcomes. The investigators are doing this study because it will help to better understand how to support health insurance and financial stress and improve self-management outcomes in young adults with type 1 diabetes. The investigators want to understand how the iHERO Toolkit helps all young adults with diabetes, but especially those on Medicaid and who are racially or ethnically diverse. The investigators will ask participants to participate at four-time points over one year. For the first time, participants will fill out online enrollment and demographic forms and 9 surveys. The 9 surveys have 8-40 short questions each, estimated to take about 45 minutes. Participants will also be asked to complete a home A1c collection with a University Hospitals team member on Zoom.

Enrollment

192 estimated patients

Sex

All

Ages

18 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age range: 18-30 years
  • Diagnosis of type 1 diabetes (T1D)
  • T1D duration for one year or longer
  • Geographical location: residing in the United States.

Exclusion criteria

  • Inability to answer questions due to cognitive status.
  • Inability to read or understand English.
  • Diagnosis of insulin-dependent diabetes that is not T1D such as cystic fibrosis-related diabetes, maturity-onset diabetes of the young, or insulin-dependent type 2 diabetes.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

192 participants in 2 patient groups

iHERO Resource Group
Experimental group
Description:
Toolkit consisting of micro-videos and supplemental online resources.
Treatment:
Behavioral: iHERO Toolkit Resource
Control
No Intervention group

Trial contacts and locations

4

Loading...

Central trial contact

Dionne Williams, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems